{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:35:56Z","timestamp":1782311756537,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1601224"],"award-info":[{"award-number":["U1601224"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2019A1515011945"],"award-info":[{"award-number":["2019A1515011945"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010031","name":"Postdoctoral Research Foundation of China","doi-asserted-by":"publisher","award":["2021M693654"],"award-info":[{"award-number":["2021M693654"]}],"id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s10549-022-06746-6","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T16:04:12Z","timestamp":1665158652000},"page":"613-622","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study"],"prefix":"10.1007","volume":"196","author":[{"given":"Qiufan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0747-5909","authenticated-orcid":false,"given":"Hanjia","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuikui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoxi","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,7]]},"reference":[{"key":"6746_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1200\/JCO.2016.71.0947","volume":"35","author":"GH Lyman","year":"2017","unstructured":"Lyman GH, Somerfield MR, Bosserman LD et al (2017) Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 35:561\u2013564. https:\/\/doi.org\/10.1200\/JCO.2016.71.0947","journal-title":"J Clin Oncol"},{"key":"6746_CR2","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1056\/NEJMoa012782","volume":"349","author":"U Veronesi","year":"2003","unstructured":"Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546\u2013553. https:\/\/doi.org\/10.1056\/NEJMoa012782","journal-title":"N Engl J Med"},{"key":"6746_CR3","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S1470-2045(06)70947-0","volume":"7","author":"U Veronesi","year":"2006","unstructured":"Veronesi U, Paganelli G, Viale G et al (2006) Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 7:983\u2013990. https:\/\/doi.org\/10.1016\/S1470-2045(06)70947-0","journal-title":"Lancet Oncol"},{"key":"6746_CR4","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/SLA.0b013e3181c0e92a","volume":"251","author":"U Veronesi","year":"2010","unstructured":"Veronesi U, Viale G, Paganelli G et al (2010) Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg 251:595\u2013600. https:\/\/doi.org\/10.1097\/SLA.0b013e3181c0e92a","journal-title":"Ann Surg"},{"key":"6746_CR5","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.1200\/JCO.2005.03.228","volume":"23","author":"AD Purushotham","year":"2005","unstructured":"Purushotham AD, Upponi S, Klevesath MB et al (2005) Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 23:4312\u20134321. https:\/\/doi.org\/10.1200\/JCO.2005.03.228","journal-title":"J Clin Oncol"},{"key":"6746_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jnci\/djj158","volume":"98","author":"RE Mansel","year":"2006","unstructured":"Mansel RE, Fallowfield L, Kissin M et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98:599\u2013609. https:\/\/doi.org\/10.1093\/jnci\/djj158","journal-title":"J Natl Cancer Inst"},{"key":"6746_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/SLA.0b013e31812e6a73","volume":"247","author":"G Zavagno","year":"2008","unstructured":"Zavagno G, De Salvo GL, Scalco G et al (2008) A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella\/GIVOM trial. Ann Surg 247:207\u2013213. https:\/\/doi.org\/10.1097\/SLA.0b013e31812e6a73","journal-title":"Ann Surg"},{"key":"6746_CR8","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/annonc\/mdn746","volume":"20","author":"G Canavese","year":"2009","unstructured":"Canavese G, Catturich A, Vecchio C et al (2009) Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial. Ann Oncol 20:1001\u20131007. https:\/\/doi.org\/10.1093\/annonc\/mdn746","journal-title":"Ann Oncol"},{"key":"6746_CR9","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11:927\u2013933. https:\/\/doi.org\/10.1016\/S1470-2045(10)70207-2","journal-title":"Lancet Oncol"},{"key":"6746_CR10","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/cncr.28499","volume":"120","author":"R Agresti","year":"2014","unstructured":"Agresti R, Martelli G, Sandri M et al (2014) Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09\/98). Cancer 120:885\u2013893. https:\/\/doi.org\/10.1002\/cncr.28499","journal-title":"Cancer"},{"key":"6746_CR11","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1245\/s10434-016-5177-4","volume":"23","author":"G Canavese","year":"2016","unstructured":"Canavese G, Bruzzi P, Catturich A et al (2016) Sentinel lymph node biopsy versus axillary dissection in node-negative early-stage breast cancer: 15-year follow-up update of a randomized clinical trial. Ann Surg Oncol 23:2494\u20132500. https:\/\/doi.org\/10.1245\/s10434-016-5177-4","journal-title":"Ann Surg Oncol"},{"key":"6746_CR12","doi-asserted-by":"publisher","first-page":"452","DOI":"10.6004\/jnccn.2020.0016","volume":"18","author":"WJ Gradishar","year":"2020","unstructured":"Gradishar WJ, Anderson BO, Abraham J et al (2020) Breast cancer, version 3.2020, NCCN clinical practice guidelines in oncology. j natl compr canc netw 18:452\u2013478. https:\/\/doi.org\/10.6004\/jnccn.2020.0016","journal-title":"j natl compr canc netw"},{"key":"6746_CR13","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1245\/ASO.2006.05.017","volume":"13","author":"C Cox","year":"2006","unstructured":"Cox C, White L, Allred N et al (2006) Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy. Ann Surg Oncol 13:708\u2013711. https:\/\/doi.org\/10.1245\/ASO.2006.05.017","journal-title":"Ann Surg Oncol"},{"key":"6746_CR14","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.ejso.2006.11.017","volume":"33","author":"GP Kuijt","year":"2007","unstructured":"Kuijt GP, van de Poll-Franse LV, Voogd AC et al (2007) Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection. Eur J Surg Oncol 33:832\u2013837. https:\/\/doi.org\/10.1016\/j.ejso.2006.11.017","journal-title":"Eur J Surg Oncol"},{"key":"6746_CR15","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.ejso.2008.09.006","volume":"35","author":"I Langer","year":"2009","unstructured":"Langer I, Guller U, Hsu-Schmitz SF et al (2009) Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients. Eur J Surg Oncol 35:805\u2013813. https:\/\/doi.org\/10.1016\/j.ejso.2008.09.006","journal-title":"Eur J Surg Oncol"},{"key":"6746_CR16","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1200\/JCO.2009.25.9226","volume":"28","author":"H-G Moon","year":"2010","unstructured":"Moon H-G, Han W, Noh D-Y (2010) Comparable Survival Between pN0 Breast Cancer Patients Undergoing Sentinel Node Biopsy and Extensive Axillary Dissection: A Report From the Korean Breast Cancer Society. J Clin Oncol 28:1692\u20131699. https:\/\/doi.org\/10.1200\/JCO.2009.25.9226","journal-title":"J Clin Oncol"},{"key":"6746_CR17","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1002\/sim.1903","volume":"23","author":"JK Lunceford","year":"2004","unstructured":"Lunceford JK, Davidian M (2004) Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study. Stat Med 23:2937\u20132960. https:\/\/doi.org\/10.1002\/sim.1903","journal-title":"Stat Med"},{"key":"6746_CR18","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA (2015) Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med 34:3661\u20133679. https:\/\/doi.org\/10.1002\/sim.6607","journal-title":"Stat Med"},{"key":"6746_CR19","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/sim.5984","volume":"33","author":"PC Austin","year":"2014","unstructured":"Austin PC (2014) The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med 33:1242\u20131258. https:\/\/doi.org\/10.1002\/sim.5984","journal-title":"Stat Med"},{"key":"6746_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","volume":"10","author":"PC Austin","year":"2011","unstructured":"Austin PC (2011) Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 10:150\u2013161. https:\/\/doi.org\/10.1002\/pst.433","journal-title":"Pharm Stat"},{"key":"6746_CR21","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/EDE.0000000000000457","volume":"27","author":"P Ding","year":"2016","unstructured":"Ding P, VanderWeele TJ (2016) Sensitivity analysis without assumptions. Epidemiology 27:368\u2013377. https:\/\/doi.org\/10.1097\/EDE.0000000000000457","journal-title":"Epidemiology"},{"key":"6746_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.breast.2019.03.002","volume":"45","author":"CA Garcia-Etienne","year":"2019","unstructured":"Garcia-Etienne CA, Mansel RE, Tomatis M et al (2019) Trends in axillary lymph node dissection for early-stage breast cancer in Europe: Impact of evidence on practice. The Breast 45:89\u201396. https:\/\/doi.org\/10.1016\/j.breast.2019.03.002","journal-title":"The Breast"},{"key":"6746_CR23","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00404-018-4982-3","volume":"299","author":"F Riedel","year":"2019","unstructured":"Riedel F, Heil J, Golatta M et al (2019) Changes of breast and axillary surgery patterns in patients with primary breast cancer during the past decade. Arch Gynecol Obstet 299:1043\u20131053. https:\/\/doi.org\/10.1007\/s00404-018-4982-3","journal-title":"Arch Gynecol Obstet"},{"key":"6746_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1001\/jamasurg.2013.4350","volume":"149","author":"TWF Yen","year":"2014","unstructured":"Yen TWF, Laud PW, Sparapani RA, Nattinger AB (2014) Surgeon specialization and use of sentinel lymph node biopsy for breast cancer. JAMA Surg 149:185\u2013192. https:\/\/doi.org\/10.1001\/jamasurg.2013.4350","journal-title":"JAMA Surg"},{"key":"6746_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/MLR.0000000000000832","volume":"56","author":"TWF Yen","year":"2018","unstructured":"Yen TWF, Laud PW, Pezzin LE et al (2018) Prevalence and Consequences of Axillary Lymph Node Dissection in the Era of Sentinel Lymph Node Biopsy for Breast Cancer. Med Care 56:78\u201384. https:\/\/doi.org\/10.1097\/MLR.0000000000000832","journal-title":"Med Care"},{"key":"6746_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jss.2020.03.063","volume":"254","author":"A Nayyar","year":"2020","unstructured":"Nayyar A, Strassle PD, Schlottmann F et al (2020) Disparities in the Use of Sentinel Lymph Node Dissection for Early Stage Breast Cancer. J Surg Res 254:31\u201340. https:\/\/doi.org\/10.1016\/j.jss.2020.03.063","journal-title":"J Surg Res"},{"key":"6746_CR27","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1200\/JCO.2002.07.112","volume":"20","author":"L Weir","year":"2002","unstructured":"Weir L, Speers C, D\u2019yachkova Y, Olivotto IA (2002) Prognostic significance of the number of axillary lymph nodes removed in patients with node-negative breast cancer. J Clin Oncol 20:1793\u20131799. https:\/\/doi.org\/10.1200\/JCO.2002.07.112","journal-title":"J Clin Oncol"},{"key":"6746_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/01.SLA.0000048552.84451.C5","volume":"237","author":"AP Polednak","year":"2003","unstructured":"Polednak AP (2003) Survival of lymph node-negative breast cancer patients in relation to number of lymph nodes examined. Ann Surg 237:163\u2013167. https:\/\/doi.org\/10.1097\/01.SLA.0000048552.84451.C5","journal-title":"Ann Surg"},{"key":"6746_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31451-4","author":"EP Mamounas","year":"2017","unstructured":"Mamounas EP, Kuehn T, Rutgers EJT, von Minckwitz G (2017) Current approach of the axilla in patients with early-stage breast cancer. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(17)31451-4","journal-title":"Lancet"},{"key":"6746_CR30","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00423-012-1037-2","volume":"398","author":"P Meiers","year":"2013","unstructured":"Meiers P, Cil T, Guller U, Zuber M (2013) Sentinel lymph node biopsy in early-stage breast cancer patients: improved survival through better staging? Langenbecks Arch Surg 398:687\u2013690. https:\/\/doi.org\/10.1007\/s00423-012-1037-2","journal-title":"Langenbecks Arch Surg"},{"key":"6746_CR31","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJMoa0904832","volume":"361","author":"M de Boer","year":"2009","unstructured":"de Boer M, van Deurzen CHM, van Dijck JAAM et al (2009) Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 361:653\u2013663. https:\/\/doi.org\/10.1056\/NEJMoa0904832","journal-title":"N Engl J Med"},{"key":"6746_CR32","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1056\/NEJMoa1008108","volume":"364","author":"DL Weaver","year":"2011","unstructured":"Weaver DL, Ashikaga T, Krag DN et al (2011) Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med 364:412\u2013421. https:\/\/doi.org\/10.1056\/NEJMoa1008108","journal-title":"N Engl J Med"},{"key":"6746_CR33","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S et al (2013) Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23\u201301): a phase 3 randomised controlled trial. Lancet Oncol 14:297\u2013305. https:\/\/doi.org\/10.1016\/S1470-2045(13)70035-4","journal-title":"Lancet Oncol"},{"key":"6746_CR34","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569\u2013575. https:\/\/doi.org\/10.1001\/jama.2011.90","journal-title":"JAMA"},{"key":"6746_CR35","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nrc1370","volume":"4","author":"K Pantel","year":"2004","unstructured":"Pantel K, Brakenhoff RH (2004) Dissecting the metastatic cascade. Nat Rev Cancer 4:448\u2013456. https:\/\/doi.org\/10.1038\/nrc1370","journal-title":"Nat Rev Cancer"},{"key":"6746_CR36","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1126\/science.aal3622","volume":"359","author":"ER Pereira","year":"2018","unstructured":"Pereira ER, Kedrin D, Seano G et al (2018) Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice. Science 359:1403\u20131407. https:\/\/doi.org\/10.1126\/science.aal3622","journal-title":"Science"},{"key":"6746_CR37","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1126\/science.aav0173","volume":"363","author":"C Lee","year":"2019","unstructured":"Lee C, Jeong S, Jang C et al (2019) Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation. Science 363:644\u2013649. https:\/\/doi.org\/10.1126\/science.aav0173","journal-title":"Science"},{"key":"6746_CR38","doi-asserted-by":"publisher","first-page":"108993","DOI":"10.1016\/j.celrep.2021.108993","volume":"35","author":"C Tacconi","year":"2021","unstructured":"Tacconi C, Commerford CD, Dieterich LC et al (2021) CD169+ lymph node macrophages have protective functions in mouse breast cancer metastasis. Cell Rep 35:108993. https:\/\/doi.org\/10.1016\/j.celrep.2021.108993","journal-title":"Cell Rep"},{"key":"6746_CR39","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1200\/JCO.2008.19.5750","volume":"27","author":"KY Bilimoria","year":"2009","unstructured":"Bilimoria KY, Bentrem DJ, Hansen NM et al (2009) Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol 27:2946\u20132953. https:\/\/doi.org\/10.1200\/JCO.2008.19.5750","journal-title":"J Clin Oncol"},{"key":"6746_CR40","doi-asserted-by":"publisher","first-page":"e89778","DOI":"10.1371\/journal.pone.0089778","volume":"9","author":"J Wang","year":"2014","unstructured":"Wang J, Mittendorf EA, Sahin AA et al (2014) Outcomes of sentinel lymph node dissection alone vs. axillary lymph node dissection in early stage invasive lobular carcinoma: a retrospective study of the surveillance, epidemiology and end results (SEER) database. PLoS ONE 9:e89778. https:\/\/doi.org\/10.1371\/journal.pone.0089778","journal-title":"PLoS ONE"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06746-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-022-06746-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-022-06746-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T20:25:45Z","timestamp":1667507145000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-022-06746-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6746"],"URL":"https:\/\/doi.org\/10.1007\/s10549-022-06746-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,7]]},"assertion":[{"value":"17 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or nonfinancial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study subjects were de-identified and there was no patient contact; thus, the study is exempt from an Institutional Review Board\u2019s review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}